Pregnenolone: dosage forms and which to choose

Pregnenolone is sold in several formats: from ordinary capsules to sublingual tablets and creams. On the shelf this looks like a choice “to taste,” but in fact the form affects absorption, dosing accuracy and product quality. The editorial team examined how the options differ and how to read the label so as not to overpay for marketing.

Why the dosage form matters

Pregnenolone is a steroid molecule from which the body begins the synthesis of almost all steroid hormones: progesterone, cortisol, DHEA, and further on androgens and estrogens. On its own it is poorly soluble in water and well soluble in fats. This physicochemical feature explains why manufacturers experiment with particle size, coatings and delivery methods.

When a substance is poorly soluble, its absorption in the intestine depends on how fine the particles are, whether there are fats in the stomach and how quickly the stomach empties. Therefore the same dose in different products may in theory produce different levels of pregnenolone and its metabolites in the blood. However, there are very few direct comparative studies of commercial forms against each other.

After absorption from the intestine, pregnenolone passes through the liver, where some of the molecules are sulfated or converted into other steroids. Alternative routes — through the oral mucosa or the skin — partly bypass this “first pass.” This is exactly what the marketing of sublingual tablets and creams is built on, although the real benefit of such a bypass for humans is weakly proven.

Finally, the form determines dosing accuracy. A capsule with a fixed content is easy to control, whereas a cream applied “a pea at a time” is not. For a substance that affects the hormonal cascade, accuracy matters more than convenience.

It is important to remember: the regulatory status of pregnenolone differs between countries. In the USA it is sold as a dietary supplement; in other jurisdictions it may be considered a medicinal substance or not be permitted in food supplements. Therefore the assortment and quality depend heavily on the market.

Capsules and tablets: the market standard

The most common format is gelatin or plant-based capsules with pregnenolone powder. Typical dosages on labels are 10, 25, 30, 50 and 100 mg per capsule. It is precisely the oral forms that were used in most clinical studies, so for them there is at least some database on tolerability.

In clinical work — for example, in the studies by Marx et al. in schizophrenia or Brown et al. in bipolar depression — oral pregnenolone was used in doses ranging from tens to a few hundred milligrams per day under medical supervision. These data describe study conditions, not recommendations for self-administration.

Tablets are encountered less often. They contain more excipients — binders, fillers, lubricants — which sometimes slows disintegration. For a lipophilic molecule this may mean less predictable absorption, although the editorial team did not find direct data for pregnenolone.

A practical advantage of capsules is simplicity: one unit equals a known dose, easy to record, skip or cancel. For people trying the supplement for the first time and coordinating it with a doctor, this is the most transparent option.

• Pros of capsules:a precise dose, the most data from studies, a wide choice of dosages.
• Cons:absorption depends on food intake, quality varies between brands.
• What to clarify:whether there is micronization, what coating, which excipients.

Micronized, sublingual and transdermal pregnenolone

Micronization is the grinding of powder to particles a few micrometers in size. The surface area increases and the substance dissolves faster. This technique has long been used in pharmaceutics for poorly soluble steroids, for example micronized progesterone. For pregnenolone the logic is the same, but there are few independent bioavailability comparisons.

Sublingual tablets and lozenges are designed to dissolve under the tongue. The oral mucosa has a good blood supply, and part of the substance may enter the bloodstream, bypassing the liver. However, a significant part of the dissolved preparation is still swallowed with saliva. How much the final hormonal profile differs has barely been studied in controlled trials.

Transdermal creams with pregnenolone are often sold as “bioidentical” products, sometimes combined with other steroids. Here the main problem is unpredictable dosing: the amount of cream, the area of skin, its thickness and the frequency of application change absorption several-fold. In addition, the cream can be transferred to other people through skin contact.

There are also liquid forms — drops and oil solutions. They allow finer dosing but require care with the pipette and often have a shorter shelf life after opening.

How to read the label and check quality

The first thing to look at is the name of the active substance. The label should say exactly “pregnenolone,” preferably with a specification of the form (micronized) and the amount in milligrams per serving. Wording like “hormonal complex” without disclosing the composition is a reason to put the product aside.

Second — the presence of third-party certification. Independent supplement testing programs (for example, USP Verified, NSF Certified for Sport, Informed Sport) verify that the composition matches the label and that there are no banned impurities. For athletes undergoing doping control this is especially important, since supplements with hormonal action are more often contaminated.

Third — the composition of excipients and combinations. Some products combine pregnenolone with DHEA, 7-keto-DHEA, herbal “boosters” or melatonin. Each additional ingredient complicates the assessment of effect and risks, so the editorial team advises giving preference to single-ingredient products.

Fourth — storage conditions and shelf life. Powder capsules are stable at room temperature in a dry place, whereas creams and liquids are more sensitive to heat and light. The packaging should have a batch number, a manufacturing date and the manufacturer's contacts.

1. Check the exact name of the substance and the dose per serving.
2. Look for a certificate from an independent laboratory or testing program.
3. Avoid “proprietary blends” with hidden dosages.
4. Verify the batch number, date and storage conditions.

How to choose a form for your situation

If a doctor has approved taking pregnenolone, the most logical choice is oral capsules with a small fixed dosage. They make it possible to record precisely how much of the substance entered the body and, if needed, compare well-being with test results.

Micronized capsules make sense if they cost comparably to ordinary ones: the theoretical advantage in solubility exists, but the markup is often disproportionate. The editorial team does not consider sublingual and cream forms a rational first choice because of the weak evidence base and the difficulty of controlling the dose.

Athletes subject to doping control should remember: pregnenolone is a precursor of DHEA and other androgens, and DHEA is included in the WADA Prohibited List. Before any use, it is necessary to clarify the status of the substance with the national anti-doping agency and to choose only certified products.

Regardless of the form, pregnenolone should not be regarded as a neutral “vitamin” supplement. It changes steroid metabolism, so the choice of product should be preceded by a discussion with a doctor and, if needed, hormone profile tests.

Editorial conclusions

Among all forms of pregnenolone, the most transparent are oral capsules: they are precisely the ones used in clinical studies and allow precise control of the dose. Micronization is a sensible technological solution, but not a mandatory condition.

Sublingual tablets and creams rely mostly on the marketing logic of “bypassing the liver,” while data on their efficacy and safety are limited and the dosing is unpredictable.

The main selection criteria are a transparent composition, a single-ingredient product instead of “blends,” independent certification and coordination with a doctor. The dosage form matters less than the quality of the specific manufacturer.

We also recommend reading our materials “Who should not take Pregnenolone,” “Myths about Pregnenolone” and “What to combine Pregnenolone with” to form a complete picture before deciding.

References

1. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81–151.
2. Marx CE, Keefe RS, Buchanan RW, et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology. 2009;34(8):1885–1903.
3. Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867–2873.
4. Sripada RK, Marx CE, King AP, et al. Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biol Psychiatry. 2013;73(11):1045–1053.
5. Roberts E. Pregnenolone — from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABA_A receptor. Biochem Pharmacol. 1995;49(1):1–16.
6. World Anti-Doping Agency. The World Anti-Doping Code: International Standard — Prohibited List. Montreal: WADA; current edition.